GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » TransMedics Group Inc (STU:TMDX) » Definitions » Days Sales Outstanding

TransMedics Group (STU:TMDX) Days Sales Outstanding : 68.45 (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is TransMedics Group Days Sales Outstanding?

TransMedics Group's average Accounts Receivable for the three months ended in Mar. 2024 was €66.8 Mil. TransMedics Group's Revenue for the three months ended in Mar. 2024 was €89.1 Mil. Hence, TransMedics Group's Days Sales Outstanding for the three months ended in Mar. 2024 was 68.45.

The historical rank and industry rank for TransMedics Group's Days Sales Outstanding or its related term are showing as below:

STU:TMDX' s Days Sales Outstanding Range Over the Past 10 Years
Min: 43.93   Med: 68.87   Max: 95.55
Current: 71.87

During the past 8 years, TransMedics Group's highest Days Sales Outstanding was 95.55. The lowest was 43.93. And the median was 68.87.

STU:TMDX's Days Sales Outstanding is ranked worse than
59.03% of 808 companies
in the Medical Devices & Instruments industry
Industry Median: 64.065 vs STU:TMDX: 71.87

TransMedics Group's Days Sales Outstanding declined from Mar. 2023 (73.05) to Mar. 2024 (68.45).


TransMedics Group Days Sales Outstanding Historical Data

The historical data trend for TransMedics Group's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TransMedics Group Days Sales Outstanding Chart

TransMedics Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial 76.67 99.97 74.23 64.78 69.49

TransMedics Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 73.05 75.31 73.81 70.57 68.45

Competitive Comparison of TransMedics Group's Days Sales Outstanding

For the Medical Devices subindustry, TransMedics Group's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TransMedics Group's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, TransMedics Group's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where TransMedics Group's Days Sales Outstanding falls into.



TransMedics Group Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

TransMedics Group's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (26.065 + 58.299) / 2 ) / 221.568*365
=42.182 / 221.568*365
=69.49

TransMedics Group's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (58.299 + 75.387) / 2 ) / 89.102*365 / 4
=66.843 / 89.102*365 / 4
=68.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TransMedics Group  (STU:TMDX) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


TransMedics Group Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of TransMedics Group's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


TransMedics Group (STU:TMDX) Business Description

Traded in Other Exchanges
Address
200 Minuteman Road, Andover, MA, USA, 01810
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body.